It hasn’t been fun being invested in the Cannabis space recently. A lot of eyes have been on the US side of things. The catalyst being Federal deregulation. I…
CBDs
In December 2018, we dropped an article about a company we’d spotted in the wild, a private cannabis company making moves in Africa and claiming they’d cracked the nut…
In this episode, we take a look at 4 Canadian cannabis stocks with potential. High Tide Cannabis (HITI.V), Heritage Cannabis Holding (CANN.C), Tetra Bio-Pharma (TBP.T) and VIVO Cannabis Inc.,…
What to say about Cannabis stocks. You give us some hope, and then pull the rug from under us. If you are a member of Equity Guru’s Free Trading…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Long time readers have been aware that, for some time, Equity.Guru has been a supporter of Canntab Therapeutics (PILL.C), but have been frustrated watching the company being slow on…
Revive Therapeutics (“RVV.C”) is a life sciences company that focuses on the research and development of therapeutics for rare disorders and infectious diseases. and it is prioritizing drug development…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Canntab Therapeutics (PILL.CN) is a Canadian biopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. Canntab’s…
Canntab Therapeutics (PILL.C) has been around the block and then some. The Ontario-based pharmaceutical answer to medicinal cannabis, has pioneered a patented process to turn CBD, THC and terpene…